- Abstract:
-
BACKGROUND: RTS,S is the most advanced candidate malaria vaccine but it is only partially protective and the causes of inter-individual variation in efficacy are poorly understood. Here, we investigated whether peripheral blood monocyte-to-lymphocyte ratios (ML ratio), previously shown to correlate with clinical malaria risk, could account for differences in RTS,S efficacy among phase II trial participants in Africa. METHODS: Of 11 geographical sites where RTS,S has been evaluated, pre-vaccin...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Files:
-
-
(tiff, 73.2KB)
-
(doc, 275.5KB)
-
(pdf, 353.1KB)
-
- Publisher copy:
- 10.1186/1741-7015-11-184
- Publisher:
- BioMed Central Ltd. Publisher's website
- Journal:
- BMC medicine Journal website
- Volume:
- 11
- Issue:
- 1
- Pages:
- 184
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1741-7015
- ISSN:
-
1741-7015
- URN:
-
uuid:2c6ac8d7-31f6-4b78-8d4c-4f7f4b593474
- Source identifiers:
-
418596
- Local pid:
- pubs:418596
- Copyright holder:
- Warimwe et al.
- Copyright date:
- 2013
- Notes:
- © 2013 Warimwe et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal article
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
Actions
Access Document
Authors
Funding
PATH Malaria Vaccine Initiative
More from this funder
GlaxoSmithKline Biologicals s.a.
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record